A trader works on the floor of the NYSE Tuesday....

A trader works on the floor of the NYSE Tuesday. Investors were encouraged by the easy passage in a Senate vote late Monday of Janet Yellen's nomination to take the helm at the Federal Reserve. (Jan. 7, 2014) Credit: Getty Images

Stocks closed mostly lower Wednesday as investors reacted to a better-than-expected private jobs report as well as minutes from the Federal Reserve's December policy meeting.

At the close on Wall Street, the Dow Jones industrial average was down 68.2 points at 16,462.7. The Standard & Poor's 500 index was off 0.4 point at 1,837.5. The Nasdaq composite, which climbed all day, ended with a gain of 12.4 points at 4,165.6.

FED MINUTES. The Federal Reserve released minutes from its mid-December meeting, when central bank officials surprised some investors by voting to start tapering the bank's huge bond-buying program. A majority of Fed policymakers believed the recent jobs data and other signs of an improving economy were enough to merit a reduction in stimulus. The vote led to the decision to cut the Fed's bond-buying program from $85 billion a month to $75 billion beginning in January.

JOBS, JOBS, JOBS. The big theme of the week is job news. A private survey showed U.S. businesses added the most jobs in a year in December, powered by a big gain in construction work. Payroll processor ADP said Wednesday that companies added 238,000 jobs in December, better than the 200,000 economists predicted. The ADP data sets the stage for Friday's government jobs report. Investors expect the U.S. economy created 190,000 jobs last month and the unemployment rate remained steady at 7 percent.

EARNINGS SEASON ARRIVES. Big publicly traded companies will start reporting their quarterly financial results Thursday. Dow member Chevron reports after the closing bell Thursday as well as former Dow member Alcoa. Investors are going to be looking to see if the recent improvement in the U.S. economy has translated into higher earnings for corporate America.

BIG PHARMACEUTICAL DEAL. Forest Labs closed up $10.54, or about 18 percent at $69.30 after the company said it would buy Aptalis, which specializes in treatments for gastrointestinal problems and cystic fibrosis, for $2.9 billion in cash.

Get the latest news and more great videos at NewsdayTV Credit: Newsday

Power bills may increase ... What's up on LI ... Plays of the week ... Get the latest news and more great videos at NewsdayTV

Get the latest news and more great videos at NewsdayTV Credit: Newsday

Power bills may increase ... What's up on LI ... Plays of the week ... Get the latest news and more great videos at NewsdayTV

SUBSCRIBE

Unlimited Digital AccessOnly 25¢for 6 months

ACT NOWSALE ENDS SOON | CANCEL ANYTIME